home
|
FAQ's
|
links
|
resources
|
Michigan
Journal of the American Medical Association - Prescription Drugs, Products Liability and Preemption of Tort Litigation - Catherine D. DeAngelis, MD, MPH, Phil B. Fontanarosa, MD, MBA
The New England Journal of Medicine, July 3, 2008 - Why Doctors Should Worry about Preemption - Gregory D. Curfman, M.D., Stephen Morrissey, Ph.D., and Jeffrey M. Drazen, M.D.
The Right To Sue: A Case Against Preemption, Pharmalot August 15, 2008
FDA Science and Mission at Risk - Report of the Subcommittee on Science and Technology, FDA Docket - November 2007
The FDA Exposed: An Interview With Dr. David Graham, the Vioxx Whistleblower - by Manette Loudon
Stealth Tort Reform: How the Bush Administration’s Aggressive Use of the Preemption Doctrine Hurts Consumers - by Margaret H. Clune*
The Role of Litigation in Defining Drug Risks - by Aaron S. Kesselheim, MD, JD, Jerry Avorn, MD
A Critical Examination of the FDA’s Efforts To Preempt Failure-To-Warn Claims
DAVID A. KESSLER* AND DAVID C. VLADECK**
The Dangers in Pre-emption - New York Times
No Haven for Dangerous Drugs - Boston Globe - 9/27/08
What is federal preemption and why should I take the time to care? - Steve Lombardi
FDA CAREER STAFF OBJECTED TO AGENCY PREEMPTION POLICIES -
UNITED STATES HOUSE OF REPRESENTATIVES COMMITTEE ON OVERSIGHT AND GOVERNMENT REFORM MAJORITY STAFF REPORT OCTOBER 2008
The Court Confronts a Grievous Injury
- New York Times Editorial 11/7/08
VIDEO - Access Denied -
Alliance for Justice
resources
Preview
Dingell, Stupak to Investigate FDA’s Medical Device Approval Process
Lawmakers Question Whether FDA Knowingly Allowed Unsafe & Ineffective Medical Devices into U.S. Market
letter written on behalf of a large group of CDRH scientists and physicians who state that CDRH managers have “corrupted and interfered with the scientific review of medical devices.”
letter sent today to FDA Commissioner Andrew C. von Eschenbach, Dingell and Stupak requested a briefing on what actions the Commissioner has taken to date and how the Commissioner intends to resolve all issues raised by the CDRH scientists and physicians.
The Supreme Court, Preemption, and Malpractice Liability